Chairman of China Netherlands Life Insurance, Li Jianying, has been approved for appointment.

LightningPacketLoss · 2026-03-06T13:03:56+00:00

The Dalian Regulatory Bureau of the National Financial Regulatory Administration approved Li Jianyong to serve as a director and chairman of China Netherlands Life Insurance Co., Ltd., requiring him to strictly comply with regulatory requirements, assume office on time, and maintain continuous learning of financial laws and regulations as well as risk compliance awareness.

LightningPacketLoss

2026-03-06 13:03:56

Abstract generation in progress

On March 3rd, the Dalian Regulatory Bureau of the China Banking and Insurance Regulatory Commission issued an approval, confirming the appointment qualifications of Li Jianying as Director and Chairman of China Netherlands Life Insurance Co., Ltd.

The approval states that China Netherlands Life Insurance should require the approved personnel to strictly comply with the relevant regulatory provisions of the China Banking and Insurance Regulatory Commission, to assume their positions within two months from the date of this administrative licensing decision, and to report their appointment status in a timely manner as required. If the personnel do not assume their positions within the specified period, this approval document will become invalid, and the Dalian Financial Regulatory Bureau will handle the cancellation of the administrative license.

China Netherlands Life Insurance should supervise the approved personnel to continuously learn and master relevant laws and regulations related to economics and finance, firmly establish risk compliance awareness, familiarize themselves with their job responsibilities, and diligently perform their duties with integrity.

(China Banking and Insurance Regulatory Commission)

Editor: Qian Xiaorui

Keywords:

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.